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Scutellaria baicalensis Georgi (“huang qin”), Ligusticum chuanxiong Hort. (“chuang 
xiong”), Panax notoginseng (Burk.) F.H. Chen (“san qi”), Uncaria rhynchophylla 
(Miq.) Jackson. (“gou teng” ), Rhokiola rosea L. (“hong jing tian”) and Stephania 
tetrandra S. Moore (“fang ji”) are commonly used traditional Chinese medicine 
(TCM) for hypertensive patients. The pharmacologically active compounds found in 
these TCMs are: baicalin, ligustrazine, notoginsenoside R1, rhynchophylline, 
salidroside and tetrandrine, respectively, which possess anti-hypertensive properties 
with diverse cellular mechanisms. In this study, we attempted to evaluate a possible 
correlation of the anti-oxidative activities (using the cell-free DPPH assay) and the 
vaso-relaxation effects (using rat isolated thoracic aorta) of these compounds. In the 
anti-oxidative study, a relative order of free radical scavenging capacity (SR %) of: 
baicalin ≥ tetradrine >> salidroside ≥ ligustrazine ≥ rhynchophylline ≈ 
notoginsenoside R1 was demonstrated. In the vaso-relaxing study, a relative order of 
the maximum relaxation response (at 3 mM) of: tetradrine > baicalin >> ligustrazine > 
notoginsenoside R1 ≈ rhynchophylline > salidroside was recorded. A positive 
correlation (R
2
 = 0.7741) between the anti-oxidative activity and the vascular 
relaxation effect of the compounds evaluated was illustrated. In contrast, ascorbic acid 
only elicited a free radical scavenging activity with no apparent relaxation effect; 
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whereas nifedipine (a Ca
2+
 channel blocker) caused a marked vascular relaxation with 
no obvious free radical scavenging activity. Hence, our results suggest, for the first 
time, that the therapeutic effect (e.g. anti-hypertensive) of these TCM-oriented drugs, 
unlike the Western medicine, are probably correlated with the unique anti-oxidative 
potential of these compounds. 
 
 





Hypertension is a complex pathophysiological state that is characterized by high 
blood pressure. An elevation of the systolic and/or diastolic blood pressure increases 
the risk of damage to vital organs such as heart, brain, kidneys, adrenal glands and 
vasculature (Gardon, 2000). Oxidative stress has been implicated in the pathogenesis 
of hypertension and some of its complications (Redon et al., 2003). It is anticipated 
that antihypertensive drugs with a prominent anti-oxidative potency would serve as an 
additional benefit in the treatment of hypertension. 
In the market, there are a few anti-hypertensive drugs which possess an additional 
anti-oxidative function. For instant, carvedilol, a novel β-blocker which has been use 
clinically for several years, has an anti-oxidative property by scavenging free radicals 
(Oettl et al., 2001). In addition, thiazide diuretics have been shown to increase the 
anti-oxidative potency of plasma (in term of better anti-oxidative level measured by 
the ferric-reducing ability of plasma (FRAP) assay) in animals and hypertensive 
patients (Uehara et al., 1993; Skalska et al., 2005). 
Compounds extracted and isolated from herbs e.g. traditional Chinese medicine 
(TCM) have been used for more than a thousand years especially in the Asian 
countries (Japan, Korea and China). It is commonly agreed/believed that the ultimate 
goals in treating hypertension are to prevent hypertension-related cardiovascular 
diseases as well as to extend life expectancy with good quality (World Health 
Organization et al., 2003). Thus, in addition to the mainline research effort in studying 
 5 
Western medicines, research on finding new drugs on the prevention or treatment of 
hypertension from nature (Ballew et al., 2001; Li, 2005; Wang et al., 2006; Yan et al., 
2006) has gained an enormous momentum recently. 
In contrast to most Western medicines with which the therapeutic strategies are 
mainly based on the cause and effect principle (Li et al., 2007), the philosophy of the 
uses of TCM are simply based on a holistic and spatial perception of the individual 
with the environment (i.e. it is a quest for an overall restoration of the “upset 
equilibrium” of our body). Thus, with a completely different philosophical/therapeutic 
approach, TCM provides therapeutic effects through a multi-target organs strategy 
with an array of different mechanisms. 
In this study, six major effective constituents (baicalin, ligustrazine, 
notoginsenoside R1, rhynchophylline, salidroside and tetrandrine) were chosen and 
they are obtained from common TCM that are commonly used/prescribed in treating 
hypertension in man. These herbs are: Scutellaria baicalensis Georgi (“huang qin”), 
Ligusticum chuanxiong Hort. (“chuang xiong”), Panax notoginseng (Burk.) F.H. 
Chen (“san qi”), Uncaria rhynchophylla (Miq.) Jacks. (“gou teng” ), Rhokiola rosea L. 
(“hong jing tian”) and Stephania tetrandra S. Moore (“fang ji”) (Table 1). Apart from 
the anti-hypertensive effect, these compounds also possess other pharmacological 
effects. For example, baicalin (from Scutellaria baicalensis Georgi) has been used in 
treating inflammation, cancer and inhibited bacterial growth (Ciesielska et al., 2002; 
Woo et al., 2006). Ligustrazine (from Ligusticum chuanxiong Hort.) inhibits blood 
vessel formation and it is used in treating arrhythmia and myocardial 
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ischemia-reperfusion injury (Shu, 2006). Notoginsenoside R1 (from Panax 
notoginseng (Burk.) F.H. Chen) can delay aging, counter shock and it is used to treat 
cancer (Wang et al., 2007; Yang et al., 2005). Rhynchophylline (from Uncaria 
rhynchophylla (Miq.) Jacks.) caused bradycardia, inhibited cardiac contractility 
repression effects. In addition, it has been shown to treat ailments in the 
cardiovascular and central nervous systems (Shi et al., 2003). Salidroside (from 
Rhokiola rosea L) has been used to treat cancer, scald, anoxia and reduced blood 
glucose (Qu, 2005). Tetrandrine (from Stephania tetrandra S. Moore) has been used 
to treat cardiac arrhythmia, angina and inflammation (Liu et al., 1995; Wang et al., 
1995; Xiao et al., 1996). 
In addition to all aforementioned effects, compounds isolated from herbs, in 
general, are favones and flavones with chemical structures/groups that are good 
anti-oxidants. In view of the important roles of oxidants/free radicals in the 
development of hypertension and other cardiovascular diseases, in this study we 
tested the hypothesis that the chief active ingredients isolated from the above 
mentioned TCM herbs possess both anti-hypertensive effect and anti-oxidative 
activity. More importantly, there is a correlation between the vascular relaxation effect 
(using rat isolated aorta) and the free radical scavenging property (using the common 
cell-free DPPH assay) of the compounds studied. 
 
Materials and Methods 
Selection of TCM herbs and Compounds 
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A total of six TCM herbs were selected for this study and these herbs are 
commonly used in TCM formulae prescribed to patients with hypertension. The major 
active constituent, rather than the extracts (water/organic), of each herb, was 
evaluated in this study.  
 
Animals and Chemicals 
Wistar rats (male, 250-300 g) were obtained from Guangdong Experimental 
Animal Center (Guangzhou, PR of China). Baicalin, ligustrazine, notoginsenoside R1, 
rhynchophylline, salidroside and tetrandrine powders (>98% purity) were purchased 
from Baoji Hongyuan Biotech Ltd. (Baoji, PR of China). DPPH, phenylephrine 
hydrochloride, ascorbic acid, nifedipine and other reagents (analytical AR grade) for 
preparing the physiological salt solution were purchased from Sigma-Aldrich (St. 
Louis, MO, USA). 
 
Preparation of compounds and solutions 
Baicalin, ligustrazine, notoginsenoside R1 and rhynchophylline were dissolved in 
dimethyl sulphoxide (DMSO). Salidroside was dissolved in distilled water and 
tetrandrine was dissolved in 4 % (vol./vol.) hydrochloric acid (0.1 M) solution. 
To measure free radical scavenging property using DPPH assay, individual 
compound was diluted by distilled water to give a final concentration of 1 mg/mL. 
Solution of ascorbic acid, which was used as a positive control for comparison, was 
dissolved in distilled water. In the vaso-relaxation study, stock of individual 
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compound was firstly diluted in distilled water and further dilutions were made in 
Tyrode's solution (for composition, see next section). 
 
Measurement of free radical scavenging capacity 
The anti-oxidative activity of individual compound was measured by DPPH assay, 
based on the free radical scavenging capacity of compounds on the stable DPPH free 
radical. Methanol was used to set the blank at 515 nm. The absorbance (Acontrol) of 
DPPH (0.024 mg/mL) in methanol was measured and recorded as control at 515 nm. 
Then, each compound (1 mg/mL) was added and mixed with the control and the 
change in absorbance (Asample) was recorded until the absorbance change was ≦ 
0.003 absorbance units per minute, as described previously (Schlesier et al., 2002). 
The absorbance (Aoriginal) of individual compound in methanol (without DPPH added) 
was measured so as to eliminate the “colour interference” of each compound. The 
percentage free radical scavenging capacity (expressed as SR %) was calculated using 
the following equation (Li et al., 2007). 
100%
 A












Measurement of the vaso-relaxation effects 
The rats were anesthetized and sacrificed by decapitation, and the thoracic aortas 
were dissected from animals immediately. Fat and connective tissues around the 
thoracic aortas were carefully removed under the dissecting stereo-microscope (Leica, 
Germany). Care was taken not to touch the lumen of the thoracic aortas during 
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dissection to ensure the endothelium intact, unless otherwise stated. Four aortic rings 
(5 mm in length) were obtained from each aortic preparation and only one ring was 
used for each drug treatment. The thoracic aortic rings were mounted on an L-shaped 
metal prongs, which was connected to a force displacement MLT1030/D transducer 
(AD Instruments, Australia) coupled to the data acquisition programme (PowerLab 
8SP, AD Instruments, Australia) for continuous recording of the isometric tension 
changes. 
The mounted thoracic aortic rings were immersed in a 5 mL glass (water-jacketed) 
tissue baths containing Tyrode's solution of the following composition (mM): NaCl 
118, KCl 4.7, MgSO4 1.2, KH2PO4 1.2, NaHCO3 25, glucose 11 and CaCl2 1.8 (pH 
7.4, 37±1C), which was aerated continuously with a gas mixture of 95% O2 and 5% 
CO2. An optimal load of 10  1 mN (determined from our preliminary studies) was 
applied progressively (2 mN per min) to aortic rings. Then, tissues were allowed to 
equilibrate for about 60 min under the optimal resting tension. During the 
equilibration period, tissues were washed with drug-free Tyrode’s solution every 20 
min and the resting tension was readjusted, if necessary, before commencing the 
experiments. After equilibration, the isolated aortic rings were sensitized with 65 mM 
KCl until two consecutive contractile responses were reproducible. To exclude the 
involvement of cyclo-oxygenase cascade, indomethacin (1 M, a non-selective 
cyclo-oxygenase inhibitor) was included in the bath solution throughout the 
experiments. After equilibration, the aortic rings were challenged with phenylephrine 
(1 M). After the establishment of a sustained contraction caused by phenylephrine, 
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individual compound (3 M - 3 mM) was added cumulatively to the organ baths and 
the concentration-response curves to each compound were constructed (Cao et al., 
2006; Damiani et al., 2003). A 100 % relaxation was considered when the active 
tension returned to the basal level. 
 
Statistical analysis 
Data were expressed as means ± S.E.M., and n denotes the number of replications 
for each data point. Comparisons of parameters among different groups were made 
with one-way analysis of variance, followed by Newman-Keul’s test for multiple 
comparisons among means. In all cases, differences between treatment groups were 
considered significant at a P value < 0.05. Correlation analyses were performed using 
linear regression and the correlation of determination (R
2
). All statistical analysis tests 
were performed by using GraphPad Prism 4.02 for Windows (GraphPad Software, 
San Diego, CA, USA). 
 
Results 
Measurement of the free radical scavenging capacity 
The anti-oxidative activity of all six compounds (1 mg/mL) was measured in term 
of the percentage free radical scavenging capacity (SR %). The SR % values of six 
compounds are: baicalin (94.74 ± 1.03 %), ligustrazine (44.45 ± 0.85 %), 
notoginsenoside R1 (40.24 ± 2.86 %), rhynchophylline (40.71 ± 1.81 %), salidroside 
(48.42 ± 1.19 %) and tetrandrine (91.56 ± 0.55 %). Among all six compounds tested, 
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the anti-oxidative activity (SR %) of baicalin and tetrandrine was comparable to that 
of ascorbic acid (96.03 ± 0.02 %) (P > 0.05) whereas the SR % values of ligustrazine, 
notoginsenoside R1, rhynchophylline and salidroside were significantly lower than 
that of baicalin, tetrandrine and ascorbic acid (P < 0.001). 
 
Measurement of the vaso-relaxation effect 
Individual compound (3 μM - 3 mM) elicited a concentration-dependent 
relaxation of the phenylephrine pre-contracted aortic preparations. The maximum 
relaxation (Rmax) (observed at 3 mM) of six compounds was: baicalin (75.85 ± 
6.53 %), ligustrazine (40.16 ± 2.24 %), notoginsenoside R1 (27.68 ± 3.60 %), 
rhynchophylline (27.68 ± 4.49 %), salidroside (14.42 ± 1.45 %) and tetrandrine (100.7 
± 2.99 %) (Fig. 1). Nifedipine induced a concentration-dependent relaxation of the 
phenylephrine pre-contracted aortic rings with Rmax equal to 96.53 ± 5.45, n = 4. 
 
Relationship between the anti-oxidative activity and the vaso-relaxation effect 
In order to investigate whether there was a correlation between anti-oxidative 
activity and vaso-relaxation effect, a Scatter plot of SR % and the maximum 
relaxation was performed (Fig. 2). Our results illustrated that there was a positive 
correlation between the free radical scavenging property (SR %) and the maximum 
relaxation of the compounds tested (R
2




Our present results illustrated that all six major effective constituents from the 
TCM herbs, which are commonly used in TCM formulae prescribed to hypertensive 
patients, possess vaso-relaxation effects. It is consistent with previous data in which 
baicalin (Huang et al., 2004) and tetrandrine (Wong, 1998) have relaxation effects in 
rat isolated aortic rings. Interestingly, in the present study, both baicalin and tetradrine 
are the most potent compounds, among all six herb-originated active constituents 
examined, in relaxing phenylephrine pre-contracted rat isolated aorta. Despite the fact 
that all compounds tested possess vaso-relaxation effect (in a differential manner), 
there is no structural similarity in the chemical structures arguing the involvement of a 
common receptor type pathway. 
In addition to the vaso-relaxation effects, we have also evaluated the 
anti-oxidative properties by measuring the free radical scavenging activities using the 
cell-free DPPH assay. Consistent with a previous study (Ng et al., 2000), baicalin 
demonstrated, in our study, a comparable anti-oxidant effect as ascorbic acid tested in 
the erythrocyte heamolysis assay. For the first time, our results demonstrated that the 
free radical scavenging activity of tetrandrine was comparable to baicalin and 
ascorbic acid. Interestingly, baicalin and tetrandrine are the most potent agents, among 
all six compounds tested, in scavenging free radical. As stated above, there is no 
structural similarity which can account for the differential free radical scavenging 
activities observed. 
Oxidative stress plays an important role in the development of atherosclerosis and 
hypertension. It is now clear not only that diverse reactive oxidative species (ROS) 
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are produced in the vessel wall, but also that they individually and in combination 
contribute to many of the abnormalities associated with vascular disease (Blokhina et 
al., 2003). There is abundant evidence supporting a role of ROS in the pathogenesis of 
high blood pressure and target organ damage in animal and human hypertension 
(Rajagopalan et al., 1996; Griendling et al., 2000). 
Given the fact that there is a close relationship of ROS generation and 
cardiovascular diseases, a great deal of effort has been devoted to determine whether 
antioxidant supplementation can be beneficial in preventing or treating these 
conditions (Seifried et al., 2007). However, among all antihypertensive drugs used, 
only thiazides (Uehara et al., 1993; Skalska et al., 2005) and carvedilol (Oettl et al., 
2001) have been reported possessing an “additional” anti-oxidative activity. 
As stated in Introduction, the “philosophy” of the uses of TCM in treating 
different diseases is different from the general/common strategy of most Western 
medicines, we therefore tested whether there is a correlation between the free radical 
activities and the vaso-relaxation effects of these herbs-based active compounds. 
Interestingly, our results for the first time illustrated that there is a positive correlation 
with correlation of determination (R
2
) = 0.7741, P < 0.001 of the vaso-relaxation 
effects and the free radical scavenging potentials of these compounds. However, it is 
important to point out that no such unique correlation was observed with ascorbic acid 
(a potent anti-oxidant) and nifedipine (a potent Ca
2+
 channel blocker) (both are 
Western medicines). Taken together, our results demonstrated that compounds isolated 
from TCM herbs studied in the present study seem to possess unique “dual effects” 
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which are beneficial in treating hypertension. In addition, our results may help to 
strengthen the wisdom of the uses of herbal medicines in treating different diseases 
with an overall/holistic approach with diverse mechanisms. 
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Tables and Figures captions 
 
Figure 1. Percentage relaxation of the six compounds. Data are expressed as 
meanSEM, n=4. 
 
Figure 2. Relations of percentage free radical scavenging capacity SR% and 
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